(Q34799592)

4 August 2017

title

Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs). (English)

1 reference

4 August 2017

Shigeharu Miwa

1

1 reference

4 August 2017

Takahiko Nakajima

2

1 reference

4 August 2017

Yoshihiro Murai

3

1 reference

4 August 2017

Yasuo Takano

4

1 reference

4 August 2017

Toshiro Sugiyama

5

1 reference

4 August 2017

publication date

23 July 2008

1 reference

Journal of Gastroenterology

4 August 2017

published in

1 reference

4 August 2017

volume

43

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

531-537

1 reference

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-008-2195-4

The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-008-2195-4

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation

21 January 2018

1 reference

12 December 2020

Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital

1 reference

12 December 2020

Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours

1 reference

12 December 2020

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

1 reference

12 December 2020

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

1 reference

12 December 2020

Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors

1 reference

12 December 2020

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal

1 reference

12 December 2020

A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.

1 reference

12 December 2020

Phylogeny of the TMEM16 protein family: some members are overexpressed in cancer

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats

1 reference

12 December 2020

Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity

1 reference

12 December 2020

FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products

1 reference

12 December 2020

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications

1 reference

12 December 2020

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

10.1007/S00535-008-2195-4

Identifiers

DOI

1 reference

4 August 2017

1 reference